Drug Distributor Faces Federal Criminal Charges for Role in Opioid Epidemic
The federal government has brought the first criminal charges against a drug distributor for its role in the opioid epidemic, Reuters reports.
Health officials in Indiana say a fast-spreading outbreak of HIV in Indiana is largely due to injection drug abuse of the prescription painkiller Opana. The powerful drug is more potent, per milligram, than OxyContin.
State health officials said Wednesday they have confirmed 26 cases, and have four additional suspected cases. According to the Centers for Disease Control and Prevention, injection drug users represent 8 percent of new HIV infections annually.
Indiana State Health Commissioner Jerome Adams says most of the residents who tested positive for HIV contracted the virus recently, and may spread it to others, USA Today reports.
“Because prescription drug abuse is at the heart of this outbreak, we are not only working to identify, contact and test individuals who may have been exposed, but also to connect community members to resources for substance abuse treatment and recovery,” Adams said in a statement.
In 2011, the Food and Drug Administration (FDA) approved a new, crush-resistant formulation of Opana ER, an opioid containing oxymorphone. In 2013, the FDA denied a request from the maker of Opana to block generic forms of the drug.
The drug’s manufacturer, Endo Health Solutions, argued its newer tamper-resistant formula was more difficult to abuse than the original version of the drug, and asked that the agency not approve generic forms of the earlier version. The FDA decided that since the original Opana had not been withdrawn for reasons of safety or effectiveness, generic forms of the painkiller could continue to be approved and marketed.
The FDA also said the newer Opana ER could still be abused, and might be more easily injected than the original formulation.